Brian BUSSER

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Targeted gene integration of CRS inhibitor genes for improved immun...
- Patent number 12,221,478
- Issue date Feb 11, 2025
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene integration of NK inhibitors genes for improved immun...
- Patent number 12,209,125
- Issue date Jan 28, 2025
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene insertion for improved immune cells therapy
- Patent number 11,873,511
- Issue date Jan 16, 2024
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY
- Publication number 20240141293
- Publication date May 2, 2024
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PRO...
- Publication number 20230279440
- Publication date Sep 7, 2023
- CELLECTIS S.A.
- Alexandre JUILLERAT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE F...
- Publication number 20230138915
- Publication date May 4, 2023
- CELLECTIS
- Philippe DUCHATEAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TALE-NUCLEASES FOR ALLELE-SPECIFIC CODON MODIFICATION AND MULTIPLEXING
- Publication number 20210017545
- Publication date Jan 21, 2021
- CELLECTIS
- Alex BOYNE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED GENE INTEGRATION OF CRS INHIBITOR GENES FOR IMPROVED IMMUN...
- Publication number 20200407694
- Publication date Dec 31, 2020
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED GENE INTEGRATION OF NK INHIBITORS GENES FOR IMPROVED IMMUN...
- Publication number 20200237823
- Publication date Jul 30, 2020
- CELLECTIS
- Brian BUSSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY
- Publication number 20200224163
- Publication date Jul 16, 2020
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Brian BUSSER

Person

Patents Grantslast 30 patents

Targeted gene integration of CRS inhibitor genes for improved immun...

Targeted gene integration of NK inhibitors genes for improved immun...

Targeted gene insertion for improved immune cells therapy

Patents Applicationslast 30 patents

TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY

METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PRO...

TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE F...

TALE-NUCLEASES FOR ALLELE-SPECIFIC CODON MODIFICATION AND MULTIPLEXING

TARGETED GENE INTEGRATION OF CRS INHIBITOR GENES FOR IMPROVED IMMUN...

TARGETED GENE INTEGRATION OF NK INHIBITORS GENES FOR IMPROVED IMMUN...

TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY